SCHEMBL4487945

SCHEMBL4487945

Cc1cc(C)c2c(C#N)cn(C(c3ccc(F)cc3)c3ccc(F)cc3)c2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PDE2A O00408 1/20 0.34
AR P10275 1/20 0.33
LMNA P02545 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
LIMK1 P53667 1/20 0.33
LIMK2 P53671 1/20 0.33
GLA P06280 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4478105 0.95 KDM4E (0.37) CYP1A2CYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL4478406 0.88 KDM4E (0.41) CYP1A2CYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL4479317 0.71 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL4467111 0.69 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL4473346 0.68 ALDH1A1 (0.40) CYP1A2CYP3A4CYP2C19ALDH1A1KDM4E
SCHEMBL16247026 0.68 KDM5A (0.38) CYP1A2CYP3A4CYP2C19ALDH1A1KDM4E
SCHEMBL4469607 0.67 CYP1A2 (0.36) CYP1A2CYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL4475755 0.65 SMN1; SMN2 (0.39) CYP1A2CYP3A4CYP2C19RAB9AALDH1A1
SCHEMBL4481874 0.65 KDM4E (0.48) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL28052317 0.64 CRHR1 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582651-B2 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-01 US disclosed
US-20060167038-A1 Pyrrolopyridine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-07-27 US disclosed
EP-1535922-A1 PYRROLOPYRIDINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167038-A1 Pyrrolopyridine derivative and use thereof OPRD1, TRPV1, OPRM1 CYP1A2 936/4885CYP3A4 973/4885CYP2C19 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.